Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Stock Options of Board

S&L Dumping

in response to by
posted on Nov 16, 2007 04:28PM

"I will bet we will see the stock ownership of S&L at 10 million or under. "

I think this is wishful thinking, but it sure would be nice!

After settlement, hopefully volume will be so great, that it won't matter who decides to sell off some of their shares.

Share
New Message
Please login to post a reply